"Lipoxygenase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme of the oxidoreductase class primarily found in PLANTS. It catalyzes reactions between linoleate and other fatty acids and oxygen to form hydroperoxy-fatty acid derivatives.
| Descriptor ID |
D008084
|
| MeSH Number(s) |
D08.811.682.690.416.583.625 D12.776.556.579.374.568.750
|
| Concept/Terms |
Lipoxygenase- Lipoxygenase
- Linoleate-Oxygen Oxidoreductase
- Linoleate Oxygen Oxidoreductase
- Oxidoreductase, Linoleate-Oxygen
- Lipoxidase
|
Below are MeSH descriptors whose meaning is more general than "Lipoxygenase".
Below are MeSH descriptors whose meaning is more specific than "Lipoxygenase".
This graph shows the total number of publications written about "Lipoxygenase" by people in this website by year, and whether "Lipoxygenase" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Lipoxygenase" by people in Profiles.
-
Dynamin 2 along with microRNA-199a reciprocally regulate hypoxia-inducible factors and ovarian cancer metastasis. Proc Natl Acad Sci U S A. 2014 Apr 08; 111(14):5331-6.
-
Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis. Cancer Prev Res (Phila). 2010 Jul; 3(7):829-38.
-
Determination of endogenous tissue inflammation profiles by LC/MS/MS: COX- and LOX-derived bioactive lipids. Prostaglandins Leukot Essent Fatty Acids. 2006 Dec; 75(6):385-95.
-
Arachidonic acid metabolites, hydrogen peroxide, and EDHF in cerebral arteries. Am J Physiol Heart Circ Physiol. 2005 Sep; 289(3):H1077-83.
-
Eicosanoid metabolism in squamous cell carcinoma cell lines derived from primary and metastatic head and neck cancer and its modulation by celecoxib. Cancer Biol Ther. 2004 Sep; 3(9):847-52.
-
Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors. Biochem J. 2002 Sep 15; 366(Pt 3):901-10.
-
Simultaneous quantification of arachidonic acid metabolites in cultured tumor cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Anal Biochem. 2001 Oct 15; 297(2):183-90.
-
Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma. Neoplasia. 2001 Jul-Aug; 3(4):287-303.
-
Differential effect of 5- and 15-lipoxygenase products on ischemically sensitive abdominal visceral afferents. Am J Physiol. 1995 Jul; 269(1 Pt 2):H96-105.
-
Lipoxygenase inhibitor nafazatrom fails to attenuate postischaemic ventricular dysfunction. Cardiovasc Res. 1987 Oct; 21(10):755-60.